CNTX Context Therapeutics Inc.
$0.23▼ -2.17%
Healthcare
Other
After hours
$0.24▲ +2.43%
Oct 27, 5:22 PM ET
Volume 1.81M
Avg Volume (10D) 1.22M
Key Metrics & Fundamentals
Market Cap
$21.56M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.22 - 3.62
% vs 50 MA
-32.05%
% vs 200 MA
-84.10%
RSI-14
28.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.17
Free Cash Flow
-$11.54M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$14.96M
COGS
–
Operating Exp
$14.97M
Operating Income
-$14.97M
EBIT
-$14.97M
Pretax Income
-$14.56M
Net Income
-$14.56M
EPS (Diluted)
-0.15
Price & Volume History
Loading chart…
Recent News
New Strong Sell Stocks for October 15th
Zacks · Oct 15, 2026 3:47 AM ET
New Strong Sell Stocks for October 13th
Zacks · Oct 13, 2026 5:19 AM ET
Context drops bispecific T-cell engager on cost-cutting initiative
Pharmaceutical Technology · Aug 7, 2026 7:05 AM ET
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
GlobeNewswire · Aug 7, 2026 5:37 AM ET
Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
GlobeNewswire · Aug 5, 2026 4:14 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CNTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.